The Myocardial Protective Effects of a Moderate-potassium Blood Cardioplegia in Pediatric Cardiac Surgery
NCT01479049
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Congenital Heart Disease
Interventions
DRUG:
MP (moderate potassium) group
DRUG:
HP (High potassium) group
Sponsor
Xijing Hospital